Paul G. Allen Family Foundation   Report issue

Foundation Phase 1 Phase 4
Founded: Seattle WA United States (1988)

Organization Overview

First Clinical Trial
2003
NCT00194623
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

rimabotulinumtoxinB (Myobloc) (2 trials)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (2)

gla-se (1 trial)

id93 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystitis (Phase 4)

Cystitis, Interstitial (Phase 4)

Pelvic Pain (Phase 4)

Somatoform Disorders (Phase 4)

Syndrome (Phase 4)

Tuberculosis (Phase 1)

Tuberculosis, Pulmonary (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4